BEBT-908 in MEF2D-Rearranged Relapsed/Refractory or MRD-Positive B-Cell Precursor Acute Lymphoblastic Leukemia

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
BEBT-908 in MEF2D-Rearranged Relapsed/Refractory or MRD-Positive B-Cell Precursor Acute Lymphoblastic Leukemia	B-cell Precursor Acute Lymphoblastic Leukemia (ALL)	Recruiting	Phase 1	2026-10-02		NCT07854652

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Guangzhou BeBetter Med Co., Ltd	1
The First Affiliated Hospital of Soochow University	164

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The first affiliated hospital of soochow university	Suzhou	China	1

Clinical trials